Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. [electronic resource]
Producer: 20120308Description: 905-8 p. digitalISSN:- 1365-2125
No physical items for this record
Publication Type: Journal Article; Comment
There are no comments on this title.
Log in to your account to post a comment.